Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors

Journal of Neuro-Oncology

Volumn 18, Issue 2, 1993, Pages 139-149

  Nicolson, Garth L ^a   Nakajima, Motowo ^b   Herrmann, John L ^a   Menter, David G ^a   Cavanaugh, Philip G ^a   Park, June Sik ^c   Marchetti, Dario ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

basement membrane; blood brain barrier; endoglycosidases; growth factor receptors; growth factors; melanoma; metastasis; neurotrophins; proteases

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; COLLAGENASE; HEPARANASE; MATRIGEL; NERVE GROWTH FACTOR; NEUROTROPHIN 3; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER INVASION; CONCENTRATION RESPONSE; ENZYME INDUCTION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; MELANOMA; MOUSE; NONHUMAN; PROTEIN DEGRADATION;

ANIMAL; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; COLLAGEN; DRUG COMBINATIONS; GROWTH SUBSTANCES; LAMININ; MELANOMA, EXPERIMENTAL; MICE; PROTEOGLYCANS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028340929     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/BF01050420     Document Type: Article

References (45)

1. Biochemical interactions of tumor cells with the basement membrane
2. Cancer metastasis: tumor cell and host organ properties important in colonization of specific secondary sites
3. Tumor and host molecules important in organ preference of metastasis
4. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
5. Patterns of metastasis in human malignancies
6. The distribution of secondary growths in cancer of the breast
7. Metastases to the central nervous system
8. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma
9. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases
10. Patterned distribution of metastases from malignant melanoma in humans
11. Metastatic carcinoma of the central nervous system and dorsal root ganglia: a prospective autopsy study
12. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival
13. Brain metastasis from melanoma
14. Selection and altered properties of brain-colonizing melanoma
15. Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain-meninges-colonizing murine B16 melanoma
16. Cellular behavior of metastatic B16 melanoma in experimental blood-borne implantation and cerebral invasion
17. Differential tumor growth of blood-borne B16 melanoma variants in cerebral dura mater is related to tumor-host reactions
18. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals
19. Regional growth of different human melanomas as metastases in the brain of nude mice
20. Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain
21. Brain surface invasion and metastasis of murine malignant melanoma variants
22. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production
23. Organ-derived endothelial cells exhibit differential responsiveness to thrombin and other growth factors
24. Heparan sulfate degradation correlates with tumor invasive and metastatic properties of B16 melanoma sublines
25. Metastatic melanoma cell heparanase: characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase
26. Cathepsin B, cathepsin H, cathepsin L.
27. Cathepsin D: purification of isoenzymes from human and chicken liver
28. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials
29. A rapid in vitro assay for quantitating the invasive potential of tumor cells
30. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: Melanoma p75 functions independent of trkA
31. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials
32. r ∿ 90, 000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization
33. r 66, 000 lung-derived paracrine growth factor that preferentially stimulates the in vitro proliferation of lung metastasizing tumor ceils
34. Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers
35. Expression of organ specific antigens on capillary endothelial cells
36. Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cell cultures
37. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor
38. Growth regulatory factors for normal, premalignant and malignant human cells
39. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis
40. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells
41. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cell metastatic to the lung
42. Lung-derived growth factor that stimulates the growth of lung-metastasizing tumor cells: Identification as transferrin
43. Differential stimulation of the growth of lung-metastasizing tumor cells by lung (paracrine) growth factors: Identification of transferrin-like mitogens in lung tissue-conditioned medium
44. Basic fibroblast growth factor in human melanoma
45. Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression